SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
37 hedge funds and large institutions have $16.8M invested in Sorrento Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
-9
Holders Change %
-19.57%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
11
Reduced
15
Closed
11
Calls
$15K
Puts
$6K
Net Calls
+$9K
Net Calls Change
+$5K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$431K |
| 2 |
Renaissance Technologies
New York
|
+$292K |
| 3 |
BlackRock
New York
|
+$280K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$209K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$205K |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.38M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$832K |
| 3 |
Goldman Sachs
New York
|
-$445K |
| 4 |
ECM
Element Capital Management
New York
|
-$352K |
| 5 |
Millennium Management
New York
|
-$241K |
